Unconventional Transcriptional Response to Environmental Enrichment in a Mouse Model of Rett Syndrome by Kerr, Bredford et al.
Unconventional Transcriptional Response to
Environmental Enrichment in a Mouse Model of Rett
Syndrome
Bredford Kerr
1, Pamela A. Silva
1,2, Katherina Walz
1,2,3,4, Juan I. Young
1,3,4*
1Department of Biology, Centro de Estudios Cientı ´ficos, Valdivia, Chile, 2Department of Biochemistry, Universidad Austral de Chile, Valdivia, Chile, 3CIN (Centro de
Ingenierı ´a de la Innovacio ´n del CECS), Valdivia, Chile, 4Department of Human Genetics, John P. Hussman Institute for Human Genomics, Miller School of Medicine,
University of Miami, Miami, Florida, United States of America
Abstract
Background: Rett syndrome (RTT) is an X-linked postnatal neurodevelopmental disorder caused by mutations in the gene
encoding methyl-CpG binding protein 2 (MeCP2) and one of the leading causes of mental retardation in females. RTT is
characterized by psychomotor retardation, purposeless hand movements, autistic-like behavior and abnormal gait. We
studied the effects of environmental enrichment (EE) on the phenotypic manifestations of a RTT mouse model that lacks
MeCP2 (Mecp2
2/y).
Principal Findings: We found that EE delayed and attenuated some neurological alterations presented by Mecp2
2/y mice
and prevented the development of motor discoordination and anxiety-related abnormalities. To define the molecular
correlate of this beneficial effect of EE, we analyzed the expression of several synaptic marker genes whose expression is
increased by EE in several mouse models.
Conclusions/Significance: We found that EE induced downregulation of several synaptic markers, suggesting that the
partial prevention of RTT-associated phenotypes is achieved through a non-conventional transcriptional program.
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Introduction
Rett Syndrome (RTT, OMIM # 312750) is a severe
neurodevelopmental disorder constituting one of the leading
causes of mental retardation and autistic features in females
[1–3]. It affects approximately 1 in every 10,000 to 15,000 live
female births [4]. Classic RTT patients are characterized by
apparent normal development for the first months followed by
developmental stagnation and regression. In the regressive phase,
purposeful hand movements and any acquired speech are lost,
brain growth decelerates, and ataxia, seizures, autonomic dysfunc-
tion and autistic features develop.
Mice null for Mecp2 (Mecp2
2/y) exhibit neurological dysfunction
that ends in premature death at 6–18 weeks of age, depending on
genetic background [5–7]. Mecp2
2/y mice have abnormal gait and
movements, hypoactivity, hypotonicity, tremor, hindlimb clasping,
and irregular breathing. This phenotype manifests at 4–6 weeks
and leads to weight loss followed by death. Neurons of Mecp2 null
mice are smaller, more compactly arranged than wild type
neurons [5] and present functional impairments. Mecp2
+/2 females
develop a similar phenotype but with later onset.
Conditional deletion of Mecp2 in either embryonic or postmi-
totic neurons results in a phenotype similar to complete knockout
[5,6], suggesting that RTT is caused by dysfunction of brain
neurons. Additional support for this idea came from experiments
in which the phenotypes of the Mecp2 null mice were rescued by
neuronal expression of transgenic Mecp2 [8].
Evaluation of the features of RTT suggests that the basis of this
disease could be an alteration of neuronal plasticity and studies of
RTT mouse models support this suggestion. Long-term potenti-
ation is reduced in cortical slices of mice mutant for Mecp2 [9,10]
and loss of MeCP2 in mice results in a decrease in the total
excitatory synaptic drive, an increase in the total inhibitory drive
and an altered number of glutamatergic synapses [11–13].
Expression of BDNF, DLX5 and FXYD1, proteins that mediate
neural plasticity have been shown to be altered in brains of RTT
patients and MeCP2 mutant mice [14–19].
It has been therefore hypothesized that the RTT-like phenotype
exhibited by Mecp2 null mice is amenable of modulation by
utilizing stimuli capable of eliciting neural plasticity. The paradigm
most widely used to assess environmental-induced plasticity is
called environmental enrichment (EE), and consist of a combined
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deficits associated with experimental brain injury [20] and delays
disease onset and slows progression in mouse models of
Huntington [21,22] and Alzheimer’s disease [23].
The effects of EE on mouse models of RTT have been analyzed
with variable findings depending on the mice and enrichment
protocol used. Kondo et al. [24] found EE-induced motor
improvement in Mecp2
+/2 female mice but not in Mecp2
2/y
males, whereas Nag et al. [25] did find motor performance
amelioration in Mecp2 null male mice. In any case, the
mechanisms underlying the beneficial effects of EE on RTT-like
phenotypes have not been completely dilucidated.
Here we report that EE induces phenotypic amelioration in a
RTT mouse model trough a ‘‘non canonical’’ transcriptional
response.
Methods
Animals
In this study we used the Rett Syndrome mouse model
generated by the laboratory of Adrian Bird [(strain Mecp2
tm1.1Bird),
Wellcome Trust Centre for Cell Biology, Institute of Cell and
Molecular Biology, University of Edinburgh, Edinburgh, UK]
[5,6]. The mice we used were male mice (dubbed Mecp2
2/y)o na
129S1/SvImJ (N6) or F1s of a cross between 129/SvJ Mecp2
2/+
female and C57BL/6J males. Mice of the 129S1/SvImJ
background were used for all determinations with the exception
of the repeated anxiety test in which mice on the F1 background
were used. Animals were kept in an animal room under SPF
conditions at a room temperature of 2062uC, in a 12/12 h light/
dark cycle with free access to food and water. All the experiments
were approved by the Centro de Estudios Cientı ´ficos Care and
Use Committee.
Housing conditions
Three-week-old Mecp2
+/y and Mecp2
2/y mice were randomly
allocated to either standard condition (SC) or environmental
enrichment (EE) cages for 14 days. After this period of EE, mice
were placed back into normal cages. SC include small group
housing (4 mice per cage) in standard cages (30615 cm) and
provision of normal feed, water and bedding, whereas the cages of
the EE groups (8 mice per two-connected 30630 cage) contained a
variety of cardboard, paper and plastic objects of a diversity of
colors, that were changed daily. Food pellets were buried in the
bedding in varied places. Additionally, mice had access to a free-
running wheel to stimulate physical activity. Both types of cages
were located in the same room, in ventilated racks.
Phenotypic Testing and Behavioral Overview
All behavioral testing was done on age-matched male mice.
Routine observation for RTT-like symptoms such as clasping and
stereotypic hand movement, body weight determination and
survival were performed at weekly intervals starting from 3 weeks
of age. The level of severity of clasping was determined according
to an arbitrary scaling of clasping (from 0 to 3) based on how fast
mice clasp their feet together when picked by the tail and also on
their capability of releasing the posture. 0 (no clasping), 1
(reversible clasping), 2 (delayed but irreversible) and 3 (immediate
and irreversible). At 7 weeks of age, each mouse was subjected to a
battery of behavioral tests performed always in the same order:
elevated plus maze, open field and elevated beam test. For all
experiments the data were presented as mean 6 SEM. Statistical
significance was set at a minimum of p,0.05. Survival analysis
was conducted by means of a Kaplan–Meier survival analysis.
Footprint Ink Test
To obtain footprint tracks, the soles of the four paws were
dipped in ink and the mice were allowed to walk down an enclosed
runway lined with white paper. The resultant ink footprints were
analyzed by measuring the length of three strides for each hind leg
and the hind-base width (the distance between the right and left
hind-limb strides) from the middle portion of each run. Mean
values were used for statistical analysis.
Elevated Plus Maze
Mice were placed in the center of a cross-shaped maze elevated
45 cm from the floor with two open and two closed arms. The
behavior of the mice was observed and the time spent in either the
closed or open arm or in the center of the maze was recorded.
Motor Abilities
Motor abilities were tested by the elevated beam test, which
consists of two elevated platforms that are enclosed by walls in
every side except in the side that connects them through a 70 cm
long dowel of 0.7 cm radius. Before testing, mice were placed on
one of the platforms and allowed to habituate for 1 min, then
moved to the opposite platform for another min. Thereafter, mice
received a short training, placing them on the dowel 10 cm away
from one of the platforms. Only those mice that reached the
platform in the first 60 sec were further assessed. Next, mice were
placed in the middle of the dowel and the time of first arrival, the
total number of arrivals and the number of falls were recorded.
Real-time RT-PCR
Total RNA from hypothalamus and cortex were extracted with
Trizol (Invitrogen, Calif.) according to the method provided by the
manufacturer. RNA was treated with DNase I (Epicenter, WI,
USA) for 30 min at 37uC, quantitated by measuring absorbance at
260 nm and stored at –80uC until used. RNA (2.5 mg) was reverse
transcribed at 42uC for 60 min by using oligo dT primers and Tetra
cDNA synthesis kit (Bioline Inc, MA, USA) to synthesize single
stranded cDNA. PCR mixtures were prepared with Quantimix
Easy Syg Kit for Real Time DNA amplification and quantification
(Biotools, Spain). Quantitative Real-time RT-PCR amplifications
were performed in triplicate from 25 ng of cDNA using the Rotor-
Gene 6000 (Corbett, Australia) in a total volume of 10 ml, each
reaction containing 1 ml of diluted cDNA. The results were
analyzed with the Rotor-Gene 6000 Series Software 1.7 (Corbett)
and all values were normalized to the levels of the GAPDH mRNA.
Primers used were the following: for Syp (XM_125375) forward 5-
GGAGTTTGAGCAGTGGGTGT-3 and reverse 5-GTGGGGT-
GGAATCAGGAGTA-3, Stx1 (NM_016801) forward 5-ACAA-
AGGAGGAACTGGAGGA-3 and reverse 5-GATGCTCTGCT-
CAATGCTCT-3, Syt9 (AB026802) forward 5-CATCGACCA-
GATCCACTTGT-3 and reverse 5-TCGTTTCCTACTTGG-
CACAC-3, Syn1 (NM_013680) forward 5-TTTTGTGGTC-
TGCATCTTCC-3 and reverse 5-ACTCTTCTCTTGGGG-
GTTCA-3, PSD95 (NM_007864) forward 5-GACGCCAGC-
GACGAAGAG-3 and reverse 5-CTCGACCCGCCGTTTG-3,
Sgk-1 (NM_011361) forward 5-GATGGGCCTGAACGATTT-
TA-3 and reverse 5-TGCCCTTTCCGATCACTTTC-3, Igf1
(NM_184052) forward 5-TTGCGGGGCTGAGCTGGTGG-
AT-3 and reverse 59-GCGGGCTGCTTTTGTAGGCTTCA-3,
Igf-bp (NM_010065) forward 5-TGCCGCAGAGAAATGGA-
GGAC-3 and reverse 5-AGGGCGGCACTGCTTCTTCT-3,
Bdnf (NM_007540) forward 5-CAGTGGCTGGCTCTCTTA-
CC-3 and reverse 5- TGCTGCCATGCATAAAACAT-3, Grin2b
(NM_008171) forward 5-ACGGCAGCAAATCCTACTTCT-3
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008165) forward 5-AAGAACGGTCAGAGGTGGTT-3 and re-
verse 5-AGAAGGCAGAAGGTGACACA-3, Gap43 (NM_008083)
forward 5-GAGGAGAAGAAGGGTGAAGG-3 and reverse 5-GA-
CGGGGAGTTATCAGTGGT-3, Nefm (NM_008691) forward 5-
AGCTGGGTGATGCTTACGAC-3 and reverse 5- AGCTGCAC-
TTGAGCCTTCTC-3, Dyn1 (NM_010065) forward 5-TGGTGC-
ATTGCCTGGGTGGTGTG-3 and reverse 5-CCGATCGGC-
TGGCAGTTGGACAG-3, N-Cadh (NM_007664) forward 5-CC-
AGCAGATTTCAAGGTGGAC-3 and reverse 5-TTACAGCTA-
CCTGCCACTTTTC-3, Arc (NM_018790) forward 5-AGGAGT-
CAGTTGAGGCTCAGCAAT-3 and reverse 5-TCATGTGGT-
TCTGGATCTGGGACA-3, Crh (NM_205769) forward 5-CA-
GAGCAGTTAGCTCAGCAAGCT-3 and reverse 5- GGCCAAG-
CGCAACATTTC-3 and GAPDH (NM_008084) forward 5-AC-
CCAGAAGACTGTGGATGG-3 and reverse 5-CACATTGGGG-
GTAGGAACAC-3.
Results
Effects of EE on the phenotype of a RTT mouse model
With the objective of studying the molecular correlate of the
environmental enrichment–induced amelioration of symptoms
exhibited by RTT mouse models, we subjected mice lacking exon
3 and the coding region of exon 4 of Mecp2 (Mecp2
2/y [5,6]) to
stimulating environmental conditions. We continually exposed 3
week-old Mecp2
2/y and Mecp2
+/y mice to an enriched environment
for 14 days. We chose to initiate EE at this age since it has been
reported that starting EE at weaning ameliorates some RTT
features exhibited by different RTT mouse models [24,25] and
also because this enrichment protocol elicited a significant
enhancement in cognitive abilities in wild type mice in our hands
(Morris water maze, data not shown). The enriched environment
consisted of two cages interconnected by a dark tunnel. Inside the
cages we placed a variety of objects that were changed daily and a
running wheel. The food was placed in different locations inside
the cage and sometimes was buried in the bedding material. Social
stimulation was also provided by the cohabitation of 8 mice
instead of the standard 4 mice per cage.
At 3 weeks of age Mecp2
2/y mice did not show any overt
phenotype, but a week later they could be easily recognized by their
altered gait, reduced body weight, tremors and hindpaw clasping,
precluding us from being completely blind to the genotypes when
performing the experiments. Because of this, we were able to notice
that Mecp2
2/y mice housed in enrichment cages (Mecp2
2/y-EE)
displayed an attenuated phenotype. It was visually evident that the
movements of Mecp2
2/y mice living in EE cages were more rapid
and coordinated than their mutant littermates housed in control
cages. We also observed that the development of paw clasping, a
characteristic feature of Mecp2
2/y mice commonly presented by
mice with neurological problems, is delayed in approximately one
week in the Mecp2
2/y-EE in comparison to Mecp2
2/y-SC mice.
Home cage observations indicate that Mecp2
2/y-SC mice displayed
hindpaw clasping of a severity level arbitrarily scored as 1–2 at 4
weeks of age, and a week later it progresses to 2–3. Instead, the hind
paw clasping developed by Mecp2
2/y-EE mice was not detectable at
4 weeks of age (levels of severity 0) but started at 5 weeks following
the same course of the Mecp2
2/y-SC (level 1–2 on week 5
progressing to level 2–3 at week 6 of age).
At the end of the enrichment period, we evaluated more
systematically its effect by a phenotyping screen that included
determinationof life span,physical and behavioral characterization.
Comparison of life span of Mecp2
2/y mice subjected to
environmental enrichment (Mecp2
2/y-EE) or to standard condi-
tions (Mecp2
2/y-SC) showed that life expectancy (similar 0.5
probability survival rate, approximately 6 weeks) was not modified
by EE (figure 1A).
The enriched environment includes free access to a running
wheel and we observed that Mecp2
2/y mice spent a considerable
amount of time exercising, as their Mecp2
+/y littermates do. This
observational datum indicates that Mecp2
2/y-EE are capable of
acquiring coordinated movement. We did not detect significant
differences in body weight between Mecp2
2/y-EE and Mecp2
2/y-
SC mice at the end of the enrichment period (figure 1B).
Behavioral effects of EE
To substantiate the home cage observation that Mecp2
2/y-EE
mice movements were more coordinated than the movements of
Figure1. Environmental Enrichment does notmodify lifespan or body weight of Mecp2
2/y mice. A, Kaplan-Meier plots showing the survival
of Mecp2
2/y-SC (open circles) and Mecp2
2/y-EE (closed circles) since the initiation of the enrichment period. B, Growth curves of mice showed in A. The
body weights of Mecp2
2/y mice, irrespective of housing conditions, dropped abruptly after 14 weeks andwere therefore notincluded in the graph. Data
represent mean 6 SEM. The total number of animals in each group is shown (n). No significant differences were found between Mecp2
2/y-SC and
Mecp2
2/y-EE according to ANOVA tukey test.
doi:10.1371/journal.pone.0011534.g001
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2/y-SC mice, we compared their gait by a footprint analysis
(figure 2B). Comparison of the trail of footprints left by Mecp2
2/y-
EE and Mecp2
2/y-SC walking on a straight corridor showed that
their stride length and base width was significantly different. Both
the hind stride length and hind base width are significantly smaller
in Mecp2
2/y-EE mice than in Mecp2
2/y-SC (N=4 each genotype;
pstride length=0.053, phind-base width=0.004; figure 2A). We also
analyzed whether EE altered the motor abilities of Mecp2
2/y by
means of the open field test and the elevated beam test. Evaluation
of the novelty-induced locomotor activity on the open field showed
that although the total distance travelled by Mecp2
2/y-EE and
Mecp2
2/y-SC was similar (805.76162.5 and 701.46124.9 cm for
Mecp2
2/y-EE and Mecp2
2/y-SC, respectively), average displacement
speed was significantly faster for Mecp2
2/y-EE (42.863.5 cm/min)
than for Mecp2
2/y-SC (36.562.1 cm/min). (p=0.022, figure 2C).
These data suggest that there might be some improvement on the
neuromotor dysfunction of Mecp2
2/y mice on EE conditions.
Accordingly, we observed that Mecp2
2/y-EE mice outperformed
their Mecp2
2/y littermates housed in control conditions in the
elevated beam test, in which the mice have to walk on an elevated
thin wooden dowel to reach the safety of a partially enclosed
platform. Mecp2
2/y-EE mice reached the platform significantly
faster than the control Mecp2
2/y mice (figure 2D). In addition, the
total number of platform reachings was higher for the Mecp2
2/y-EE
(figure 2F). Moreover, the performance of enriched Mecp2
2/y mice
was similar to the performance of Mecp2
+/y mice housed either in
SC or EE (figure 2D).
Mecp2
2/ymice subjected to tests designed to measure anxietylevels
exhibit a behavior consistent with decreased anxiety (see [7] and
[26]). Notably, the behavior of the Mecp2
2/y-EE and Mecp2
2/y-SC on
the elevated plus maze was significantly different (figure 3). As
anticipated by previous reports [7,26], Mecp2
2/y-SC mice did not
show a preference for the safety of the closed arms of the maze as wild
type mice do. On the contrary, Mecp2
2/y-SC mice spent significantly
moretimeintheopenthanintheclosedarms(figure3A).However,if
the Mecp2
2/y were housed in an enriched environment, their
preference for the open arms disappears (figure 3A). These results
indicate that EE prevents the development of this phenotype. To rule
out that EE resulted in a stressful condition that increased the levels
of anxiety of Mecp2
2/y mice, we measured the expression of Crh,a
key regulator of the mammalian stress response. We found that the
expression of Crh in hypothalamus was similar in Mecp2
2/y-EE and
Figure 2. Environmental Enrichment improves neuromotor dysfunction in Mecp2
2/y mice. A, Footprint analysis showed impaired walking
patterns in Mecp2
2/y-SC mice compared with Mecp2
2/y-EE and Mecp2
+/y2SC control animals. B, Measures taken for footprint analysis .C, Speed of
movement (cm/s) was faster for Mecp2
2/y-EE than Mecp2
2/y-SC mice. D, Mecp2
2/y-EE mice displayed improved motor coordination compared with
Mecp2
2/y-SC evidenced by a shorter time to reach the platform for the first time and E, higher number of arrivals to the platform in the elevated beam
test. The total number of animals in each group is shown (n). Mean 6 SEM values are presented. A two-way repeated measures ANOVA
(genotype6condition) demonstrated differences in the mean values among the different levels of condition (F=8.06; p=0.007). Student’s t test
indicated that the Mecp2
2/y-SC group was significantly different from the other two groups (*: p,0.05).
doi:10.1371/journal.pone.0011534.g002
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2/y-SC mice (figure 4A), suggesting that the restoration of a
normal behavior on the plus maze induced by EE in Mecp2
2/ymice is
n o tj u s tac o n s e q u e n c eo fe l e v a t e ds t r e s s .S i n c em i c eo ft h e1 2 9
genetic background are not very good responders in the plus maze
test [27], as evidenced by the behavior of the Mecp2
+/y-SC on this test
(figure 3A), we decided to repeat this particular test on a B6129 F1
background. In this genetic background, the preference of Mecp2
+/y-
SC for the closed arms of the maze was more pronounced. Again,
Mecp2
2/y-SC did not show a preference for the closed arms of the
maze, but Mecp2
2/y-EE mice exhibited a behavior indistinguishable
from their wild type littermates (figure 3B), further confirming the
positive effect of EE on the plus maze phenotype of the Mecp2
2/y
mice. Motor performanceof the Mecp2
2/ymicewasalsoimprovedby
EE in this background (data not shown)
Molecular response to EE
Our results strongly suggest that a subset of phenotypic
manifestations exhibited by Mecp2-null mutants can be ameliorat-
ed by environmental stimulation. This implies that EE constitutes
a good platform for the identification of neurochemical pathways
that could serve as therapeutical targets. As a starting point in this
quest, we analyzed the expression of several candidate genes. An
increase in the expression of synaptic markers has become a
hallmark of the effects of EE. We checked the expression of
synaptic markers in 5 week old mice exposed to EE for 14 days.
We chose to determine the expression of these markers in
hypothalamus and cortex based on the behavioral changes
induced by EE in our RTT mouse model and WT mice. We
handpicked mice (on a 129 genetic background) that displayed a
visually attenuated phenotype for this analysis. Surprisingly, we
found that expression of postsynaptic density-95 (PSD95) and
synaptophysin (Syp) was significantly downregulated in hypothal-
amus of Mecp2
2/y mice under EE conditions (figure 4A). The
steady state level of PSD95 and Syp mRNAs in Mecp2
2/y-EE,
relative to Mecp2
2/y-SC, in the hypothalamus was 43.262.7 and
64.764.0%, respectively (p,0.05). A similar trend was observed
for synaptotagmin (Syt9, 72.9611.3%) and activity regulated
cytoskeletal-associated protein (Arc, 48.5617.2) although it did
not reach statistical significance (p=0.07 and 0.057, respectively).
These data contrast with the observed upregulation of synapto-
physin in the littermate wild type controls housed together with
the Mecp2
2/y-EE and therefore subjected to the exact enriched
environment (Mecp2
+/y-EE, figure 4B). Interestingly, analysis of
candidate gene expression in the cortex showed that Mecp2
2/y-EE
mice have reduced expression of syntaxin 1A (Stx1a, 42.86
13.7%,), synaptotagmin (23.6613.7%) and a trend for diminished
expression of synaptophysin (46.5616.8% p=0.06), as compared
to expression levels of Mecp2
+/y-SC (figure 4B). The EE-induced
reduction in syntaxin1A is notable, since it has been reported that
non enriched Mecp2
2/y already exhibit reduced expression of this
gene [16]. However, we did not replicate this finding; the
expression of Stx1A was similar in our Mecp2
+/y and Mecp2
2/y in
standard conditions (data not shown). We could not detect
significant changes in candidate gene expression induced by EE
in midbrain of Mecp2
2/y mice.
Discussion
Elucidating the factors that enable RTT patients to favorably
change the course of the disease is a relevant task. Animal models
are increasingly important in addressing this issue. Importantly,
the availability of mouse models of RTT has allowed researchers
to determine that the dysfunctionality caused by lack of MeCP2 is
not irrevocable. Guy et al. [28] and Giacometti et al. [29] proved
that the RTT-like symptoms of Mecp2 null mice could be fully
reversed by conditionally activating a functional copy of
MeCP2.These data provide hope for phenotypic amelioration in
RTT, but do not provide immediate therapeutic strategies since
attaining appropriate MeCP2 expression throughout the CNS is
Figure 3. Environmental Enrichment restores a normal behavior in the plus maze test. A, In the elevated plus maze, significant increases
in the percentage of time spent in open arms were seen in Mecp2
2/y-SC (129 genetic background) compared with Mecp2
+/y-SC mice. This phenotype
is reversed in the Mecp2
2/y-EE mice. B, In a B6129 F1 genetic background, Mecp2
2/y-EE mice showed a behavior indistinguishable from the Mecp2
+/y-
SC mice. Mean 6 SEM are presented. Two way ANOVA (genotype6condition) demonstrated differences in the mean values among the different
levels of Genotype (F=10.705; p=0.003) and condition (F=7.516; p=0.011). Post hoc Student’s t test detected statistical differences between
groups, *: p,0.05.
doi:10.1371/journal.pone.0011534.g003
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correct MeCP2 dosage only to neurons that lack it, given that the
slightest perturbation in MeCP2 level seems deleterious. In fact,
we [30] and Giacometti et al. [29] demonstrated that postnatal
reactivation of MeCP2 in mutant animals is not sufficient to rescue
the complete null phenotype unless MeCP2 levels are restored to
the expected wild-type levels and done so in a sufficient number of
neurons. A recent paper [31], indicating that glial cells lacking
MeCP2 have negative effects on the growth of neuronal dendrites
implies that for a full phenotypic rescue, restitution of MeCP2
should also include non neuronal cells.
In addition, it has been shown that exposure to an enriched
environment was able to modify the disease course in mouse
models of RTT. Kondo et al. [24] reported that Mecp2
+/2 females,
but not males, housed in enriched conditions were spared the
motor discoordination exhibited by control Mecp2
+/2 females.
This group subjected the mice to EE from 4 weeks of age until the
end of the study (at 10 weeks for males and 30 weeks for females).
Thus, the authors proposed that a functional copy of Mecp2 was
necessary for benefiting from EE. On the other hand, Nag et al.
[25] showed that EE, starting at weaning age, precluded the
development of hypoactivity in Mecp2 null males.
In this study we show that Mecp2
2/y mice housed from 3 to 5
weeks of age in an enriched environment that favors social
interaction, exercise and exploratory activities display an attenu-
ated neuromotor phenotype. Mecp2
2/y-EE mice are distinguish-
able from Mecp2
2/y-SC mice by a trained observer, they are more
active, their movements are more coordinated and have in general
a healthier look. Mecp2
2/y-EE mice are as capable as wild type
mice of traversing a thin elevated beam, a task that requires good
motor coordination. In addition, Mecp2
2/y mice moved faster and
the ataxic gait was observably improved in conditions of EE.
Further, we observed that the behavior of the Mecp2
2/y-EE
mice on the plus maze was similar to the behavior exhibited by
wild type mice, in contrast to Mecp2
2/y-SC mice that behaved as if
they have decreased anxiety. However, the Mecp2
2/y-SC data (i.e.,
increased time spent in the open arms of the plus maze) could be
alternatively interpreted as resulting from abnormal perception of
the environment, as if the mutant mice are not completely able to
perceive the danger of the unprotected walkway instead of a
reflection of decreased anxiety. We favor this interpretation, based
on the reports of elevated anxiety observed in RTT patients and
the abnormal expression of genes that are induced during the
stress response by glucocorticoids [32,33]. Thus we propose that
EE restores MeCP2 mutant’s ability to appropriately perceive
environmental clues.
Our data support the notion that EE improves phenotypic
manifestations of mouse models of RTT [24,25]. Notwithstanding
differences in the mouse models utilized (Mecp2
tm1Tam [24],
Mecp2
1lox [25] or Mecp2
tm1.1Bird [this report]), the enrichment para-
digms (continuous from 4 weeks of age [24], continuous from
3 weeks of age [25] or transient from 3 to 5 weeks of age [this
report]) and the methods used to test its effects, EE is capable of
eliciting improvement in some RTT like phenotypes.
The EE-induced phenotypic amelioration suggests that it could
constitute a good platform to identify critical neurobiologic
alterations that underlie phenotypic improvements in RTT mouse
models. It has been postulated that the beneficial effects of EE are
mediated largely by modulation of expression of a number of
genes involved in neuronal structure, synaptic signaling and
plasticity [34–36]. We thus compared the expression of synaptic
markers in Mecp2-null mice subjected to EE or SC. Surprisingly,
we observed decreased expression of synaptic proteins in brains of
Mecp2
2/y-EE mice. Synaptophysin and PSD95 were downregu-
lated in the hypothalamus and syntaxin 1a and synaptotagmin
were significantly decreased in the cortex of Mecp2
2/y mice under
EE conditions. On the contrary, control wild type mice subjected
to EE showed the expected elevation in synaptophysin levels. In
addition to a diametrically opposed response of Mecp2
2/y mice to
what was expected based on previous studies of EE transcriptional
effects with respect to synaptophysin, syntaxin 1a and synapto-
tagmin, we also did not detect changes in gene expression of genes
shown to respond to EE such as IGF-I, IGFbp, BDNF, Grin2B,
Gria, Gap43, Nefm, Dyn1 and N-Cadh in brains of Mecp2
2/y-EE
mice. It is also notable that in spite of an observable EE-induced
motor improvement in Mecp2
2/y mice, we did not detect EE-
induced changes in gene expression in midbrain, suggesting that
the motor amelioration could be mediated by brain regions
different from midbrain structures.
The dynamics of synaptic connectivity is determined by a
balance between synapse formation and elimination that initiates
Figure 4. Environmental Enrichment on Mecp2
2/y-EE mice
induces a decrease in the expression of a set of synaptic
plasticity-related genes. A, A significant difference in the steady-
state level of mRNA for Syp, PSD95 and SGK-1 was observed in
hypothalamus of Mecp2
2/y-EE in comparison with in Mecp2
2/y-SC mice
assessed by qRT-PCR. Syp WT: The expected EE-induced increase in Syp
in Mecp2
+/y-EE (normalized to Mecp2
+/y-SC) is shown as a darker bar. B,
In samples from cerebral cortex, differences were detected in Syt9,
Stx1a and SGK-1. The results are expressed as percentage of the
Mecp2
2/y-SC control group. * p,0.05 by Student’s test (n=5 for each
group).
doi:10.1371/journal.pone.0011534.g004
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shown that the control of synapse number is subverted in mice
lacking MeCP2. At 2 weeks of age, Mecp2
2/y mice have a reduced
number of glutamatergic synapses that is compensated by 5 weeks
of age when housed in standard conditions [13]. The EE-induced
decrease in mRNA levels for synaptic proteins in Mecp2
2/y mice
suggests a reduction in synapse number. Since our EE program
started when mice were of 3 weeks of age, we cannot differentiate
whether the results reflect an interference in the process that
culminates with synapse number compensation or a loss of
synapses during EE. Nevertheless, our data strengthen the
hypothesis of alterations in synaptic function underlying the
pathophysiology of Rett syndrome.
Although the relevance of these molecular findings to the partial
behavioral amelioration induced by EE is yet unknown, they
indicate that neurons lacking MeCP2 are unable to respond to EE
through canonical pathways.
Note Added in Proof: While this manuscript was under
review, Lonetti et al. (Biol Psychiatry. 2010, 67:657–65.) reported
that early and continuous EE (starting at postnatal day 10)
improved motor coordination and motor learning in Mecp2
2/y
male mice. They also show that this EE paradigm induced
alterations in synaptic density, LTP, and augmented BDNF levels.
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